|
|
|
40
|
31712
|
ENBREL 50MG INJ (PFI/STO) ETANERCEPT
|
ETANERCEPT
|
ENBREL
|
4X50MG
|
C
|
2,966.78
|
741.70
|
INJECTION
|
0
|
PFS
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
9200
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
41
|
31712
|
ENBREL 50MG INJ (PFI) ETANERCEPT (C)
|
ETANERCEPT
|
ENBREL
|
4X50MG
|
C
|
2995.86
|
748.9662
|
PFS
|
1
|
BOX
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
9200
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
2024-04-01
|
2026-03-31
|
|
IV
|
6
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
42
|
31712
|
ENBREL 50MG/ML INJ (PFI) ETANERCEP (C)
|
ETANERCEPT
|
ENBREL
|
4X50MG
|
C
|
2,995.87
|
748.97
|
PFS
|
0
|
BOX
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
9200
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
2026-04-01
|
|
|
IV
|
0
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
41
|
3171B
|
ERELZI 50MG INJ SOLN (BCH) ETANERCEPT (C)
|
ETANERCEPT
|
ERELZI
|
4X50MG
|
C
|
1596.83
|
399.2063
|
BOX
|
1
|
PFS
|
BCH
|
SANDOZ
|
COL
|
COLLINS LTD
|
|
9236
|
DISEASE MODIFYING ANTIRHEUMATIC AGENTS
|
2024-04-01
|
2026-03-31
|
|
SC
|
6
|
DISEASE MODIFYING ANTIRHEUMATIC AGENTS
|
|
|
|
|
42
|
3171B
|
ERELZI 50MG/ML SOLN FOR INJ (BCH) (C)
|
ETANERCEPT
|
ERELZI
|
4X50MG
|
C
|
1,596.83
|
399.21
|
PFS
|
0
|
PFS
|
BCH
|
SANDOZ
|
COL
|
AVENTA BARBADOS
|
|
9236
|
DISEASE MODIFYING ANTIRHEUMATIC AGENTS
|
2026-04-01
|
|
|
SC
|
0
|
DISEASE MODIFYING ANTIRHEUMATIC AGENTS
|
|